|
|
|
|
|
Purple Biotech Ltd (PPBT) |
|
|
|
| |
Purple Biotech Ltd 's Yearly Net Cash Flow Growth 5 Years |
| |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
PPBT Annual Net Cash Flow Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
| Y / Y Annual Net Cash Flow Change |
-3.17 % |
156.49 % |
-15.07 % |
30.81 % |
- |
| Annual Net Cash Flow (in millions $) |
$10.89 |
$11.25 |
$4.39 |
$5.16 |
$3.95 |
| Annual Net Cash Flow Growth
Comment |
Purple Biotech Ltd experienced detoriation of Annual Net Cash Flow for the fiscal year ended 2022 by -3.17% to $ 10.89 millions, compare to $ 11.25 in Annual Net Cash Flow reported in the previous year. The decline in company's annual Net Cash Flow accelerated, from the 156.49 % gain, in the fiscal year ended 2021.
Purple Biotech Ltd Annual Income Statement
|
|
You need to upgrade your Flash Player
|
| Companies with similar 2022 Annual Net Cash Flow within Healthcare Sector | Y/Y Net Cash Flow Growth % | 2022 Annual Net Cash Flow | | Abbott Laboratories |  -97.20 % | $ 83.000 millions | | Organon and Co | | | |
